Export: +91 9820402906   Domestic: +91 7710003340 | HR: +91 9137757219

Thiamine Mononitrate + Riboflavin + Pyridoxine HCl + Niacinamide + Calcium Pantothenate Tablets

High-potency B-complex formulation options containing vitamins B1, B2, B3, B5 and B6 for nutritional supplementation and correction of documented deficiencies under professional guidance.

Composition & Product Overview

Active ingredients: Thiamine Mononitrate (Vitamin B1), Riboflavin (Vitamin B2), Pyridoxine Hydrochloride (Vitamin B6), Niacinamide/Nicotinamide (Vitamin B3) and Calcium Pantothenate (Vitamin B5).

Formulation options supplied for development/registration: B1 10/50/100 mg; B2 10/15 mg; B6 3/10 mg; Niacinamide 50/100 mg; Calcium Pantothenate 10/50 mg. Final label claim must match the approved market-specific formula.

Therapeutic category: Vitamin B-Complex / Nutritional Supplement.

B2B enquiry: Contract manufacturing and export enquiries: +91 7710003340.

Categories

Product Information

Thiamine Mononitrate + Riboflavin + Pyridoxine HCl + Niacinamide + Calcium Pantothenate Tablets is listed for pharmaceutical business-to-business enquiries. Exact active ingredients, formulation, strength, pack configuration and manufacturer details should be confirmed against the product label and approved technical documentation before ordering.

Description

1. Product Introduction

Healthy Life Pharma Pvt. Ltd. offers manufacturing and B2B supply support for therapeutic B-complex tablets containing thiamine mononitrate, riboflavin, pyridoxine hydrochloride, niacinamide and calcium pantothenate.

These water-soluble B vitamins act as coenzymes in carbohydrate, protein and energy metabolism and support normal neurologic, skin and mucosal function. Higher-potency formulas may be used when clinically appropriate to correct or prevent specific vitamin deficiencies. Exact indications, strengths and claims should follow the approved product label and local regulations.

Manufacturing/export certifications and regulatory status should be verified against current valid documents before publication or tender submission.

2. Product Specifications

Product NameTherapeutic B-Complex Tablets
Generic DescriptionThiamine Mononitrate + Riboflavin + Pyridoxine HCl + Niacinamide + Calcium Pantothenate Tablets
Vitamin B1Thiamine Mononitrate: 10 mg / 50 mg / 100 mg formulation options
Vitamin B2Riboflavin: 10 mg / 15 mg formulation options
Vitamin B6Pyridoxine HCl: 3 mg / 10 mg formulation options
Vitamin B3Niacinamide (Nicotinamide): 50 mg / 100 mg formulation options
Vitamin B5Calcium Pantothenate: 10 mg / 50 mg formulation options
Dosage FormOral tablet; sugar-coated or film-coated presentation may be developed subject to approved specification
Therapeutic ClassVitamin B-Complex / Nutritional Supplement
StandardMarket-specific pharmacopoeial or approved in-house specification, as applicable
Packaging / Shelf LifeTo be confirmed from the approved stability data and registered pack

The listed strengths are alternative formulation options from the supplied brief and should not be interpreted as one fixed tablet composition.

3. Manufacturing Technology

B-complex formulations require control of blend uniformity, moisture, light exposure and coating performance because individual vitamins differ in dose and stability.

  • Blend uniformity: Appropriate staged blending/geometric dilution may be used when ingredients are present at materially different concentrations.
  • Granulation and compression: Process parameters are selected to achieve flow, weight variation, hardness, friability and disintegration targets defined in the approved master formula.
  • Light/moisture protection: Riboflavin is light-sensitive, so suitable coating and packaging can help protect product quality.
  • Coating: Film or sugar coating may improve swallowability, taste/odor masking and appearance when validated for the specific formulation.

Any specific excipients, binders, pigments, humidity limits, equipment or process claims should be published only if supported by the actual manufacturing record.

4. Quality Assurance

Finished-product testing should follow the registered specification and applicable pharmacopoeial requirements. Typical quality controls may include:

  • Identification and assay of the declared vitamins using validated analytical methods.
  • Uniformity of dosage units / weight variation, as applicable.
  • Disintegration and, where required, dissolution testing.
  • Related substances or degradation testing where specified.
  • Microbial quality and packaging integrity testing where applicable.

Any overages used to compensate for stability loss must be scientifically justified, documented and compliant with the target market's regulations.

5. Therapeutic and Nutritional Role

This combination supplies several B vitamins with complementary metabolic roles:

  • Thiamine (B1): contributes to normal carbohydrate metabolism and neurologic function.
  • Riboflavin (B2): participates in cellular energy metabolism and helps maintain normal tissues.
  • Niacinamide (B3): is a precursor of NAD/NADP coenzymes used in cellular energy reactions.
  • Calcium Pantothenate (B5): supplies pantothenic acid, a component of coenzyme A.
  • Pyridoxine (B6): is involved in amino-acid metabolism and neurotransmitter synthesis.

Use may be appropriate for prevention or treatment of deficiencies when dietary intake is inadequate or requirements are increased. Specific disorders such as beriberi, pellagra, neurologic syndromes or severe deficiency can require targeted therapy and should not be self-treated with a general combination tablet.

Important: suspected Wernicke encephalopathy is a medical emergency and commonly requires urgent parenteral thiamine rather than relying on an oral B-complex tablet.

6. Export and Regulatory Support

For B2B partners, product registration support may include technical documentation, specifications, analytical data and commercial documentation depending on the destination market and contractual scope.

  • Dossier support: CTD / ACTD or country-specific documentation where available.
  • Certificates: COA and other certificates only where current and applicable.
  • Packaging: blister, bottle or institutional pack options subject to stability and registration requirements.
  • Logistics: export arrangements can be planned according to destination-country requirements.

Claims such as WHO-GMP, COPP, FSC, Star Export House status, exact shelf life and specific approved markets should be verified from current documentation before use.

7. Frequently Asked Questions

Q: What vitamins are included?
A: The formulation contains vitamins B1, B2, B3, B5 and B6 in the form of thiamine mononitrate, riboflavin, niacinamide, calcium pantothenate and pyridoxine hydrochloride.
Q: Are all listed strengths present in one tablet?
A: Not necessarily. The supplied brief lists alternative strengths. The final marketed composition must follow the approved label for that product.
Q: Why can urine turn bright yellow?
A: Riboflavin is intensely yellow and excess amounts can cause harmless bright-yellow urine.
Q: Does niacinamide cause the same flushing as niacin?
A: Niacinamide (nicotinamide) is much less likely to cause the characteristic flushing associated with nicotinic acid (niacin).
Q: Can this product replace treatment for severe vitamin deficiency?
A: Not always. Severe or disease-specific deficiency can require different doses, routes or individual vitamins under medical supervision.

8. Dosage and Administration

Dose should follow the approved product label and the patient's nutritional/clinical requirements. Because the supplied brief contains several alternative strengths, a universal “one tablet two or three times daily” instruction is not appropriate for every possible formulation.

  • Swallow the tablet with water unless the registered label states otherwise.
  • For deficiency treatment, clinicians should select a dose based on the deficient vitamin, severity, diet, comorbidities and concurrent medicines.
  • Do not use high-potency vitamin products for prolonged periods without appropriate professional guidance.

9. Side Effects and Precautions

  • Gastrointestinal: nausea or stomach upset may occur.
  • Urine color: riboflavin can cause harmless bright-yellow urine.
  • Vitamin B6: prolonged excessive pyridoxine intake can cause sensory neuropathy; total intake from all supplements and medicines should be considered.
  • Levodopa interaction: pyridoxine can reduce the effect of levodopa when levodopa is used without a peripheral dopa-decarboxylase inhibitor such as carbidopa or benserazide.
  • Niacinamide: unlike nicotinic acid, it generally causes much less flushing; high doses may still cause adverse effects and require medical oversight.
  • Seek medical advice for persistent neurologic symptoms, severe mouth/tongue inflammation, malnutrition, alcoholism-related illness or suspected specific deficiency.

10. Storage Instructions

  • Store according to the registered label, typically in a cool, dry place protected from excessive heat, moisture and light.
  • Keep the tablets in the original, tightly closed packaging.
  • Keep out of reach of children.

Exact storage temperature and shelf life should be based on approved stability data for the final formulation and pack.

For professional and B2B reference. Prescribing information, manufacturing claims, certification and market-specific approvals require verification.